List/tripsitting: Difference between revisions

Line 120:

<h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4>

*[[CBD]] (''non-inhalant ROA'')

*[[CBD]] (''non-inhalant ROA''):

** CBD heated to 250-300 C will partially be converted to THC.<ref>{{cite journal |last1=Czégény |first1=Z |last2=Nagy |first2=G |last3=Babinszki |first3=B |last4=Bajtel |first4=Á |last5=Sebestyén |first5=Z |last6=Kiss |first6=T |last7=Csupor-Löffler |first7=B |last8=Tóth |first8=B |last9=Csupor |first9=D |title=CBD, a precursor of THC in e-cigarettes. |journal=Scientific reports |date=26 April 2021 |volume=11 |issue=1 |pages=8951 |doi=10.1038/s41598-021-88389-z |pmid=33903673 |pmc=8076212}}</ref>

** CBD:THC ratio: 50:1<ref>{{cite journal | vauthors=((Englund, A.)), ((Oliver, D.)), ((Chesney, E.)), ((Chester, L.)), ((Wilson, J.)), ((Sovi, S.)), ((De Micheli, A.)), ((Hodsoll, J.)), ((Fusar-Poli, P.)), ((Strang, J.)), ((Murray, R. M.)), ((Freeman, T. P.)), ((McGuire, P.)) | journal=Neuropsychopharmacology | title=Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with ~~four different~~ CBD~~:THC ratios | pages=1–8 | date=16 November 2022 | url=https://www.nature.com/articles/s41386-022-01478-z | issn=1740-634X | doi=10.1038/s41386-022-01478-z | access-date=25 November 2022~~}}~~</ref>~~

</li>

</ul>

@@ Line 120: / Line 120: @@
                  <li class="featured list-item">
 <h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4>
-*[[CBD]] (''non-inhalant ROA'')
+*[[CBD]] (''non-inhalant ROA''):
-** CBD heated to 250-300 C will partially be converted to THC.<ref>{{cite journal |last1=Czégény |first1=Z |last2=Nagy |first2=G |last3=Babinszki |first3=B |last4=Bajtel |first4=Á |last5=Sebestyén |first5=Z |last6=Kiss |first6=T |last7=Csupor-Löffler |first7=B |last8=Tóth |first8=B |last9=Csupor |first9=D |title=CBD, a precursor of THC in e-cigarettes. |journal=Scientific reports |date=26 April 2021 |volume=11 |issue=1 |pages=8951 |doi=10.1038/s41598-021-88389-z |pmid=33903673 |pmc=8076212}}</ref>
+{{Risks with inhaled CBD}}
-** CBD:THC ratio: 50:1<ref>{{cite journal | vauthors=((Englund, A.)), ((Oliver, D.)), ((Chesney, E.)), ((Chester, L.)), ((Wilson, J.)), ((Sovi, S.)), ((De Micheli, A.)), ((Hodsoll, J.)), ((Fusar-Poli, P.)), ((Strang, J.)), ((Murray, R. M.)), ((Freeman, T. P.)), ((McGuire, P.)) | journal=Neuropsychopharmacology | title=Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios | pages=1–8 | date=16 November 2022 | url=https://www.nature.com/articles/s41386-022-01478-z | issn=1740-634X | doi=10.1038/s41386-022-01478-z | access-date=25 November 2022}}</ref>
                  </li>
              </ul>